Ling‐Ming Tseng
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies 33
- Cancer Genomics and Diagnostics 17
- Oncology top 0.2%
- HER2/EGFR in Cancer Research 50
- Cancer Treatment and Pharmacology 19
- Cancer Cells and Metastasis 17
- Cancer-related Molecular Pathways 14
- Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer 13
-
- Advanced Breast Cancer Therapies 25
- Co-authors
- Hsin‐Chen LeeTadeusz PieńkowskiPinuccia ValagussaYoung‐Hyuck ImLuca GianniGiulia BianchiSeock‐Ah ImJuan de la Haba-Rodríguez
- Journals
- Cancer Research (14 papers)Journal of Clinical Oncology (11 papers)Breast Cancer Research and Treatment (7 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Ling‐Ming Tseng
219 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 3.0k
- Oncology 4.9k
- Radiology, Nuclear Medicine and Imaging 1.3k
- Molecular Biology 3.6k
- Pulmonary and Respiratory Medicine 1.6k
Countries citing papers authored by Ling‐Ming Tseng
This map shows the geographic impact of Ling‐Ming Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Ming Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Ming Tseng more than expected).
Fields of papers citing papers by Ling‐Ming Tseng
This network shows the impact of papers produced by Ling‐Ming Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Ming Tseng. The network helps show where Ling‐Ming Tseng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ling‐Ming Tseng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2023 | 19 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 8 | |
| 10 | 2019 | 31 | |
| 11 | 2019 | 10 | |
| 12 | 2019 | 15 | |
| 13 | 2015 | 71 | |
| 14 | 2014 | 54 | |
| 15 | 2013 | 83 | |
| 16 | Quality of life assessment in Taiwanese patients with bone metastases from breast cancer receiving zoledronic acid. | 2013 | 1 |
| 17 | 2012 | 17 | |
| 18 | 2010 | 110 | |
| 19 | 2009 | 65 | |
| 20 | 2006 | 18 |
About Ling‐Ming Tseng
Ling‐Ming Tseng is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Genetics, having authored 228 papers that have together received 8.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (50 papers), Breast Cancer Treatment Studies (33 papers), Advanced Breast Cancer Therapies (25 papers), Cancer Treatment and Pharmacology (19 papers), Cancer Genomics and Diagnostics (17 papers), Cancer Cells and Metastasis (17 papers), Cancer-related Molecular Pathways (14 papers) and PI3K/AKT/mTOR signaling in cancer (13 papers). The work is most often cited by research in Cancer Research (3.0k citations), Oncology (4.9k citations), Radiology, Nuclear Medicine and Imaging (1.3k citations), Molecular Biology (3.6k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Ling‐Ming Tseng has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Hsin‐Chen Lee, Tadeusz Pieńkowski, Pinuccia Valagussa, Young‐Hyuck Im, Luca Gianni, Giulia Bianchi, Seock‐Ah Im, Juan de la Haba-Rodríguez, Semiglazov Vf and Aňa Lluch. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Breast Cancer Research and Treatment, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.